Video

Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy

Source: Ajinomoto Bio-Pharma Services

Discover how Forge Biologics’ state-of-the-art, 200,000 sq. ft. facility, cutting-edge proprietary technologies, and comprehensive suite of specialized services set the standard in AAV manufacturing. Designed to support developers at every stage of their journey—from initial discovery through clinical development and ultimately to delivery—Forge’s dedicated team of experts provides tailored solutions to accelerate innovation.

With a focus on precision, scalability, and quality, our facility and services empower developers to bring their groundbreaking gene therapies to life, ensuring successful outcomes at every critical milestone.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Ajinomoto Bio-Pharma Services